Journal article

Effects of oral clenbuterol on the clinical and inflammatory response to endotoxaemia in the horse

LA Cudmore, T Muurlink, T Whittem, SR Bailey

Research in Veterinary Science | ELSEVIER SCI LTD | Published : 2013

Abstract

Pro-inflammatory cytokines, such as IL-1β and TNFα, play a major role in activating leukocytes and endothelial cells during the systemic inflammatory response to endotoxin in the horse. β2 agonist drugs, such as clenbuterol, inhibit leukocyte activation. This study aimed to determine the effects of oral clenbuterol on clinical and leukocyte responses, including production of TNFα, in an in vivo endotoxin challenge model. In a randomised crossover design, horses received either clenbuterol or a placebo product prior to the administration of low dose endotoxin (30ng/kg over 30min). Clinical signs were measured and leukocyte counts and serial blood samples were obtained over 6h. Pre-treatment w..

View full abstract

University of Melbourne Researchers

Grants

Funding Acknowledgements

The authors are grateful to Virbac Animal Health Australia for funding the study and supplying the test compound. They would also like to thank Dr. Josephine Holmes for her assistance in administrating the test and placebo compounds, ensuring the researchers remained blinded. Thanks also go to Leanne Salerno for her diligent care of the horses, and to Mr. Garry Anderson for his statistical advice.